Werewolf Therapeutics (HOWL): 10% owner sold ~$3.7K
RA CAPITAL MANAGEMENT, 10% owner at Werewolf Therapeutics, sold ~$3.7K of Werewolf Therapeutics shares.
- ~$3.7K
- Approx. value · 9,939 sh @ $0.37
- 331K
- Holds after · shares reported
- Traded
- Jun 16, 2026
- Filed
- Jun 16, 2026
What stands out in this filing
- The sale was 2.9% of the shares this insider held before it; the filing reports 331,414 shares, held indirectly afterwards.
- 9,939 shares at an average of $0.37 each, as reported on the form.
- No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Calculated by OQRO from this filing and the public records it holds. Facts about the record, not a reason for the trade and not a signal.
The story around this disclosure
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
- May 8, 2026Insider · 2 peopleInsiders: 3 sales (~$481K)
- May 11, 2026Insider · 2 peopleInsiders: 3 sales (~$81K)
- May 12, 2026Insider · 2 peopleInsiders: 3 sales (~$108K)
- May 13, 2026InsiderDirector sold ~$24K of HOWL shares in the open market
- May 18, 2026InsiderDirector sold ~$11K of HOWL shares in the open market
- May 19, 2026InsiderDirector sold ~$28K of HOWL shares in the open market
- May 20, 2026InsiderDirector sold ~$37K of HOWL shares in the open market
- May 21, 2026InsiderDirector sold ~$15K of HOWL shares in the open market
- May 22, 2026InsiderDirector sold ~$39K of HOWL shares in the open market
- May 26, 2026InsiderDirector sold ~$32K of HOWL shares in the open market
- May 27, 2026InsiderDirector sold ~$39K of HOWL shares in the open market
- May 28, 2026InsiderDirector sold ~$13K of HOWL shares in the open market
- May 29, 2026InsiderDirector sold ~$15K of HOWL shares in the open market
- Jun 1, 2026InsiderDirector sold ~$38K of HOWL shares in the open market
- Jun 2, 2026InsiderDirector sold ~$13K of HOWL shares in the open market
- Jun 3, 2026InsiderDirector sold ~$12K of HOWL shares in the open market
- Jun 4, 2026InsiderDirector sold ~$8.8K of HOWL shares in the open market
- Jun 5, 2026InsiderDirector sold ~$10K of HOWL shares in the open market
- Jun 8, 2026InsiderDirector sold ~$24K of HOWL shares in the open market
- Jun 9, 2026Insider · 2 peopleInsiders: 3 sales (~$165K)
- Jun 10, 2026Insider · 1 personInsiders: 2 sales (~$17K)
- Jun 11, 2026Insider · 1 personInsiders: 2 sales (~$100K)
- Jun 12, 2026Insider · 1 personInsiders: 2 sales (~$68K)
- Jun 15, 2026Insider · 1 personInsiders: 2 sales (~$50K)
- Jun 16, 2026 · this disclosureInsider10% owner sold ~$3.7K of HOWL shares in the open market
What came next
- Jun 16, 2026Insider10% owner sold ~$52K of HOWL shares in the open market
- Jun 17, 2026Insider · 1 personInsiders: 2 sales (~$146K)
- Jun 29, 2026InsiderDirector sold ~$47K of HOWL shares in the open market
- Jul 6, 2026InsiderDirector sold ~$11K of HOWL shares in the open market
- Jul 7, 2026InsiderDirector sold ~$33K of HOWL shares in the open market
- Jul 31, 2026Company filing · Form 8-K · ResultsReported its results
- Aug 14, 2026Company filing · Form 8-K · Material agreementSigned an important agreement
- Aug 21, 2026Company filing · Form 8-K · Material agreement, Unregistered sharesSigned an important agreement, and sold new shares without registering them (and 1 more item)
How to read SEC Form 4
Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.
Full guide: What is an SEC Form 4?
What else is on file for Werewolf Therapeutics
For Werewolf Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.
These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its HOWL page.
Other recent filings by RA CAPITAL MANAGEMENT, L.P., 10% owner
- SEC Form 4 at Spyglass Pharma (SGP)Nov 18, 2026
- SEC Form 4 at Pepgen (PEPG)Nov 17, 2026
- SEC Form 4 at Bambusa Therapeutics (BBTX)Nov 3, 2026
- SEC Form 4 at Bambusa Therapeutics (BBTX)Nov 3, 2026
- SEC Form 4 at Bambusa Therapeutics (BBTX)Nov 3, 2026
The full history of RA CAPITAL MANAGEMENT, L.P., 10% owner is on the profile page.
How this filing works
Explore the data
Common questions
Which Werewolf Therapeutics (HOWL) insider traded, and how much?
RA CAPITAL MANAGEMENT, 10% owner at Werewolf Therapeutics, sold ~$3.7K of Werewolf Therapeutics shares. 9,939 shares at $0.37.
When did it happen, and when was it made public?
Traded: Jun 16, 2026. Filed: Jun 16, 2026.
What stands out in this filing?
The sale was 2.9% of the shares this insider held before it; the filing reports 331,414 shares, held indirectly afterwards. 9,939 shares at an average of $0.37 each, as reported on the form. No footnote on the form refers to a pre-arranged trading plan (Rule 10b5-1).
Is the dollar amount exact?
It is the number of shares multiplied by the price the insider reported on the form. A grant, a gift or an option exercise has no market price, so those show shares only.
Where does this information come from?
From the SEC Form 4, a public record. The link to the official record is on this page, and OQRO copies its figures without changing them.
What else has been disclosed about Werewolf Therapeutics recently?
For Werewolf Therapeutics, OQRO holds 1 fund holdings report (13F) dated in the last 90 days. They are listed on the HOWL page.
Does this mean HOWL stock is a buy or a sell?
No. This page describes one public filing. A filing does not say why someone traded and is not a forecast, so OQRO gives no recommendation.
Is OQRO free?
Yes. Every page of OQRO is free with an account, which takes a minute with Google and needs no card. Only the AI assistant is paid.
Other disclosures at Werewolf Therapeutics
- SEC Schedule 13GNov 16, 2026
- SEC Form 4Jul 8, 2026
- SEC Form 4Jul 8, 2026
- SEC Form 4Jun 29, 2026
- SEC Form 4Jun 22, 2026
- SEC Form 4Jun 22, 2026
Everything OQRO holds on this company is on its HOWL page.
This is one filing. OQRO holds the rest
Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.
OQRO is free for everyone. No card, no trial
OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data
